AWM Investment Company Inc. acquired a new stake in shares of Strata Critical Medical (NASDAQ:SRTA - Free Report) during the second quarter, according to its most recent filing with the SEC. The fund acquired 2,821,468 shares of the company's stock, valued at approximately $14,869,000. Strata Critical Medical accounts for approximately 1.3% of AWM Investment Company Inc.'s investment portfolio, making the stock its 24th biggest holding. AWM Investment Company Inc. owned 3.26% of Strata Critical Medical as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in SRTA. Seelaus Asset Management LLC increased its holdings in shares of Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company's stock worth $102,000 after purchasing an additional 6,000 shares during the period. Granite Investment Partners LLC boosted its stake in Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company's stock valued at $76,000 after buying an additional 7,911 shares during the period. Principal Financial Group Inc. purchased a new position in Strata Critical Medical during the first quarter worth about $537,000. Dimensional Fund Advisors LP grew its position in Strata Critical Medical by 11.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company's stock worth $6,759,000 after buying an additional 172,154 shares in the last quarter. Finally, Quantinno Capital Management LP grew its position in Strata Critical Medical by 98.7% during the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company's stock worth $599,000 after buying an additional 71,155 shares in the last quarter. Hedge funds and other institutional investors own 47.36% of the company's stock.
Wall Street Analyst Weigh In
Separately, Weiss Ratings downgraded shares of Strata Critical Medical from a "hold (c)" rating to a "hold (c-)" rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $8.00.
Read Our Latest Report on Strata Critical Medical
Strata Critical Medical Stock Up 3.7%
Shares of SRTA opened at $6.19 on Wednesday. Strata Critical Medical has a one year low of $3.85 and a one year high of $6.50. The business has a 50-day moving average of $5.49. The stock has a market capitalization of $547.63 million, a price-to-earnings ratio of -154.75 and a beta of 2.25.
Insider Buying and Selling at Strata Critical Medical
In other Strata Critical Medical news, Director Reginald Love sold 5,091 shares of the business's stock in a transaction on Monday, August 10th. The stock was sold at an average price of $5.75, for a total value of $29,273.25. Following the sale, the director directly owned 146,481 shares of the company's stock, valued at approximately $842,265.75. The trade was a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Amir Cohen sold 4,655 shares of the company's stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $27,324.85. Following the completion of the transaction, the chief accounting officer owned 146,608 shares in the company, valued at approximately $860,588.96. The trade was a 3.08% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 71,147 shares of company stock valued at $417,022 over the last ninety days. Company insiders own 15.50% of the company's stock.
About Strata Critical Medical
(
Free Report)
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Strata Critical Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Strata Critical Medical wasn't on the list.
While Strata Critical Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
